Osteoporos Int (2011) 22:739 DOI 10.1007/s00198-010-1346-7
ERRATUM
Erratum to: Do RANKL inhibitors (denosumab) affect inflammation and immunity? S. Ferrari-Lacraz & S. Ferrari
Published online: 17 July 2010 # International Osteoporosis Foundation and National Osteoporosis Foundation 2010
Erratum to: Osteoporos Int DOI 10.1007/s00198-010-1326-y Owing to an error by the authors, an inappropriate publication was cited as reference 71. The correct reference is: 71. Verdrengh M, Bokarewa M, Ohlsson C, Stolina M, Tarkowski A (2010) RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis. Bone 46(3):752–758
The online version of the original article can be found at http://dx.doi. org/10.1007/s00198-010-1326-y. S. Ferrari-Lacraz Transplantation Immunology Unit, Division of Immunology and Allergy and Division of Laboratory Medicine, Department of Medical and Genetic Laboratories, Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland S. Ferrari Division of Bone Diseases, Department of Rehabilitation and Geriatrics, Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland S. Ferrari (*) Service des Maladies Osseuses, Geneva University Hospital (HUG), 6, rue Gabrielle-Perret-Gentil, 1211 Geneva 14, Switzerland e-mail:
[email protected]
